drugset / Trial / NCT02195687
BOTOX® in the Treatment of Crow's Feet Lines in China
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared with placebo in patients with moderate to severe crow's feet lines (lateral canthal lines).
Timeline
- Start
- 2014-09
- Primary completion
- 2015-02
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 24 iu | Other |